Neuromelanin detection by magnetic resonance imaging (MRI) and its promise as a biomarker for Parkinson’s disease

The diagnosis of Parkinson’s disease (PD) occurs after pathogenesis is advanced and many substantia nigra (SN) dopamine neurons have already died. Now that therapies to block this neuronal loss are under development, it is imperative that the disease be diagnosed at earlier stages and that the respo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:NPJ Parkinsons Dis
Autores principales: Sulzer, David, Cassidy, Clifford, Horga, Guillermo, Kang, Un Jung, Fahn, Stanley, Casella, Luigi, Pezzoli, Gianni, Langley, Jason, Hu, Xiaoping P., Zucca, Fabio A., Isaias, Ioannis U., Zecca, Luigi
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group UK 2018
Materias:
Review Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5893576/
https://ncbi.nlm.nih.gov/pubmed/29644335
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41531-018-0047-3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares